Inovalon to Support National Vaccine Adherence Programs
November 09 2020 - 8:43AM
Inovalon (Nasdaq: INOV), a leading provider of cloud-based
platforms empowering data-driven healthcare, today announced the
launch of an Inovalon ONE® Platform configuration supporting
multiple national vaccine adherence initiatives.
The program involves organizations from across
the healthcare ecosystem, including global pharmaceutical
organizations, patient engagement services companies, and health
plans, with the Inovalon ONE® Platform serving as the program’s
overall national technology platform. One of the world’s leading
pharmaceutical companies and largest manufacturers of vaccines
within the U.S., and a variety of leading health plans have engaged
with the program with additional top global pharmaceutical
companies and health plans expected to join.
“Adherence to vaccination schedules is critical
for providing maximum effectiveness against vaccine-preventable
diseases in the community,” said Keith Dunleavy, M.D., Inovalon’s
chief executive officer and chairman of the board. “We are pleased
to bring to bear the scale of the Inovalon ONE® Platform and its
vast primary source datasets to empower successful adherence to
vaccine schedules, especially at a time when we have seen the
COVID-19 pandemic disrupt routine vaccinations, let alone the need
for COVID-19 related vaccination initiatives.”
A wide array of vaccinations are of rising
importance to public health as highlighted by the emergence of the
COVID-19 pandemic. Education, timely and complete vaccination
consistent with recommended schedules is of public health
importance, as absent or incomplete vaccination may result in
either suboptimal or lack of disease protection for that patient
while also supporting herd immunity within the overall population.
However, patients frequently fail to attain appropriate and timely
vaccinations, including course completion for vaccines that require
multiple doses and/or follow-on doses.
A recent analysis found that Medicare alone
spent $106 billion on vaccine-preventable diseases over a 3-year
period (2016–2018). More broadly, studies show that vaccines help
to prevent up to 3 million deaths each year. Vaccine series
completion, where patients are recommended to receive multiple
doses, is a persistent challenge. Once initiating a vaccine series,
dramatic patient attrition often occurs for subsequent doses.
Individual and community protection that vaccines provide is
compromised when these doses are missed or delayed. The Centers for
Disease Control and Prevention’s Advisory Committee on Immunization
Practices (ACIP) recommends vaccine outreach programs to improve
vaccine series compliance.
The Inovalon ONE® Platform Vaccine Adherence
Program leverages established healthcare ecosystem connectivity,
data integration, normalization, and analyses across engaged health
plan patients to assess clinical applicability as well as adherence
to the applicable ACIP immunization schedule and guidelines. On
behalf of the partnered health plans, identified patients are then
contacted through omni-channel engagement modalities with
information to educate and facilitate applicable vaccinations. The
Inovalon ONE® Platform thereafter monitors ongoing data flows for
data confirming subsequent treatment confirmations. The offering is
provided in coordination with pharmaceutical companies, vaccine
manufacturers, retail clinics, provider networks, and other related
elements of the healthcare ecosystem, in collaboration with
participating health plans to support a global focus on
strengthening vaccine education and adherence initiatives.
About the Inovalon ONE®
Platform
The Inovalon ONE® Platform is an integrated
cloud-based platform of nearly 100 individual proprietary
technology toolsets and deep data assets able to be rapidly
configured to empower the operationalization of large-scale,
data-driven healthcare initiatives. Each proprietary technology
toolset, referred to as a Module, is informed by the data of
billions of medical events within Inovalon’s proprietary datasets.
Combinations of Modules are configured to empower highly
differentiated solutions for client needs quickly and in a highly
scalable fashion. The flexibility of the Platform’s modular design
enables clients to integrate the Platform capabilities with their
own internal capabilities or other third-party solutions. The
Platform brings to the marketplace a highly extensible,
national-scale capability to interconnect with the healthcare
ecosystem on a massive scale, aggregate and analyze data in
petabyte volumes, arrive at sophisticated insights in real time,
and drive meaningful impact wherever it is analytically identified
best to intervene and intuitively visualize data and information to
inform business strategy and execution.
About Inovalon
Inovalon is a leading provider of cloud-based
platforms empowering data-driven healthcare. Through the Inovalon
ONE® Platform, Inovalon brings to the marketplace a national-scale
capability to interconnect with the healthcare ecosystem, aggregate
and analyze data in real time, and empower the application of
resulting insights to drive meaningful impact at the point of care.
Leveraging its Platform, unparalleled proprietary datasets, and
industry-leading subject matter expertise, Inovalon enables better
care, efficiency, and financial performance across the healthcare
ecosystem. From health plans and provider organizations, to
pharmaceutical, medical device, and diagnostics companies,
Inovalon’s unique achievement of value is delivered through the
effective progression of “Turning Data into Insight, and Insight
into Action®.” Supporting thousands of clients, including 24 of the
top 25 U.S. health plans, 22 of the top 25 global pharma companies,
19 of the top 25 U.S. healthcare provider systems, and many of the
leading pharmacy organizations, device manufacturers, and other
healthcare industry constituents, Inovalon’s technology platforms
and analytics are informed by data pertaining to more than one
million physicians, 565,000 clinical facilities, 324 million
Americans, and 58 billion medical events. For more information,
visit www.inovalon.com.
Contact:
Kim E. CollinsSenior Vice President, Corporate
Communications kcollins@inovalon.com301-809-4000 x1473Hulus
AlpayVice President, Investor
Relationshalpay@inovalon.com301-809-4000 x1237
Inovalon (NASDAQ:INOV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Inovalon (NASDAQ:INOV)
Historical Stock Chart
From Sep 2023 to Sep 2024